References.
1. Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL,
Kulkarni PA. Postacute COVID-19: An Overview and Approach to
Classification. Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509.
2. Sokolowska M, Lukasik ZM, Agache I, Akdis CA, Akdis D, Akdis M, et
al. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics,
and perspectives-A report of the European Academy of Allergy and
Clinical Immunology (EAACI). Allergy. 2020 Oct;75(10):2445-2476.
3. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC,
et al. Immune response to SARS-CoV-2 and mechanisms of
immunopathological changes in COVID-19. Allergy. 2020
Jul;75(7):1564-1581.
4. Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al.
Interleukins (from IL-1 to IL-38), interferons, transforming growth
factor β, and TNF-α: Receptors, functions, and roles in diseases. J
Allergy Clin Immunol. 2016 Oct;138(4):984-1010.
5. Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell
BW, et al. Endothelial dysfunction and immunothrombosis as key
pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021 Apr 6:1-11.
6. Pasrija R, Naime M. The deregulated immune reaction and cytokines
release storm (CRS) in COVID-19 disease. Int Immunopharmacol. 2021
Jan;90:107225.